NCT07398313Completed
Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women
Effectiveness of Prehabilitation on Pelvic Function and Quality of Life Among Post-Surgical Cervical Cancer Women
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
This parallel-group randomized controlled trial evaluated the effectiveness of a four-week multimodal prehabilitation programme on pelvic function and quality of life among women with cervical cancer undergoing radical hysterectomy. Thirty-nine eligible participants were randomly allocated to either the intervention group or the control group. The intervention group received a supervised multimodal prehabilitation programme comprising aerobic exercise, pelvic floor muscle training, progressive resistance training, flexibility exercises, breathing exercises, and patient education for four weeks prior to surgery, while the control group received standard preoperative care. Following radical hysterectomy, both groups underwent an identical postoperative rehabilitation programme. Pelvic function was assessed using transabdominal ultrasound by measuring bladder base displacement during voluntary pelvic floor muscle contraction. Pelvic floor symptoms were evaluated using the Pelvic Floor Distress Inventory-20 (PFDI-20), and health-related quality of life was assessed using a validated quality-of-life questionnaire. Outcome assessments were performed at baseline, four weeks before surgery prior to initiation of the intervention, and repeated four weeks after surgery. The study investigated whether a structured prehabilitation programme improved pelvic function, reduced pelvic floor-related symptoms, and enhanced postoperative quality of life compared with standard preoperative care among women undergoing radical hysterectomy for cervical cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 14 Jan 2026
- Start date
- 17 Jun 2025
- Primary completion date
- 7 Feb 2026
- Lead sponsor
- Saveetha University
- Diseases
- Cervical cancer
- NCT number
- NCT07398313
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 17 Jun 2025 to the primary completion date, 7 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of locally advanced or metastatic cervical cancer
- Active urinary tract infection at the time of assessment
- Any medical condition contraindicating participation in structured exercise programs
Other
- Presence of cardiopulmonary comorbidities limiting exercise tolerance
- Cognitive impairments interfering with understanding or compliance with the intervention
Who the study is looking for
- Women aged between forty and sixty years
- Confirmed diagnosis of cervical cancer
- Preoperative diagnosis of early-stage cervical cancer
- Planned to undergo radical hysterectomy
- Ability to actively engage in pelvic floor and resistance training protocols
- Willingness to participate in the study
- Provision of written informed consent prior to inclusion
Age in the registry: 40 years to 60 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SaveethaUniversity Coordinator of this site? Confirm its status | Chennai | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.